According to Dynavax Technologies
's latest financial reports the company has $0.62 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.62 B | 7.07% |
2022-12-31 | $0.58 B | 161.28% |
2021-12-31 | $0.22 B | 278.88% |
2020-12-31 | $58.69 M | 608% |
2019-12-31 | $8.29 M | -86.85% |
2018-12-31 | $63.06 M | -68.4% |
2017-12-31 | $0.19 B | 123.71% |
2016-12-31 | $89.2 M | -52.32% |
2015-12-31 | $0.18 B | 86.18% |
2014-12-31 | $0.10 B | -46.06% |
2013-12-31 | $0.18 B | 62.24% |
2012-12-31 | $0.11 B | 14.96% |
2011-12-31 | $99.88 M | 91.67% |
2010-12-31 | $52.11 M | 717.3% |
2009-12-31 | $6.37 M | -60.53% |
2008-12-31 | $16.15 M | -58.71% |
2007-12-31 | $39.13 M | -50.51% |
2006-12-31 | $79.07 M | 6.33% |
2005-12-31 | $74.36 M | 24.2% |
2004-12-31 | $59.87 M | -204.68% |
2003-12-31 | $-57.2 M | 1.47% |
2002-12-31 | $-56.38 M | 63.79% |
2001-12-31 | $-34.42 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $89.28 B | 14,253.32% | ๐บ๐ธ USA |
Amgen AMGN | $6.23 B | 901.81% | ๐บ๐ธ USA |
Biogen BIIB | $14.79 B | 2,279.05% | ๐บ๐ธ USA |
Gilead Sciences GILD | $22.74 B | 3,556.97% | ๐บ๐ธ USA |
Merck MRK | $37.63 B | 5,949.94% | ๐บ๐ธ USA |
AstraZeneca AZN | $39.16 B | 6,196.06% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $16.28 B | 2,518.35% | ๐ฌ๐ง UK |
Agenus
AGEN | -$0.15 B | -123.85% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $8.12 B | 1,206.28% | ๐ฎ๐ฑ Israel |